Empowering patients to combat cancer
and preserve their quality of life.
and preserve their quality of life.
Redefining drug delivery with on-target, sustained therapy using thermogelling polymers.
Technology
Absco Therapeutics unlocks the full potential of immune-modulating therapies using thermogelling polymers that transform from liquid to solid at body temperature, holding position on injection to create controlled-release drug depots optimal for immune education.
ABS005
A novel treatment for high-grade Cervical Intraepithelial Neoplasia (CIN2/3)
Problem:
The current standard of care for CIN2/3 relies on surgical excision, which carries reproductive risks and does not address the underlying HPV infection, contributing to recurrence.
Solution:
ABS005 combines a clinically validated drug with Absco’s proprietary thermogelling polymer system to enable sustained intralesional delivery. ABS005 offers a non-surgical treatment that has the potential to preserve cervical integrity and reproductive health, treat HPV, and reduce recurrence.
196,000
U.S. women diagnosed annually
with CIN2/3
with CIN2/3
Source: CDC (McClung et al., 2019)
Preserve reproductive health
Prevent recurrence
Prevent recurrence
A versatile platform for targeted therapeutics.
Our platform can incorporate
small molecules, proteins,
and nucleic acids.
small molecules, proteins,
and nucleic acids.
Live image tracing for confirmed
on-target clinical administration.
on-target clinical administration.
We are advancing our platform in
multiple therapeutic areas, starting
with cancers and precancers.
multiple therapeutic areas, starting
with cancers and precancers.
Leadership
Steve Linderman MD, PhD
Founder & CEO
David Altreuter PhD
EVP Product Development
Morgan Stykel PhD
Research Strategy and Operations
Advisors
Jennifer Scalici MD
Gynecologic Oncology
Christine Bunt
Serial Biotech CEO, Investor
Jeff Finer MD, PhD
Serial Biotech CEO, VC Partner
Cheryl Larrivee-Elkins
Regulatory & Quality
Shashi Ramaiah DVM, PhD
Nonclinical Toxicology
Board of Directors
Giovanni Traverso MD, PhD
Founder
Avik Som MD, PhD
Founder
Steve Linderman MD, PhD
Founder & CEO
Support and Honors
